<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38469293</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The immunobiology of SARS-CoV-2 infection and vaccine responses: potential influences of cross-reactive memory responses and aging on efficacy and off-target effects.</ArticleTitle><Pagination><StartPage>1345499</StartPage><MedlinePgn>1345499</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1345499</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1345499</ELocationID><Abstract><AbstractText>Immune responses to both SARS-CoV-2 infection and its associated vaccines have been highly variable within the general population. The increasing evidence of long-lasting symptoms after resolution of infection, called post-acute sequelae of COVID-19 (PASC) or "Long COVID," suggests that immune-mediated mechanisms are at play. Closely related endemic common human coronaviruses (hCoV) can induce pre-existing and potentially cross-reactive immunity, which can then affect primary SARS-CoV-2 infection, as well as vaccination responses. The influence of pre-existing immunity from these hCoVs, as well as responses generated from original CoV2 strains or vaccines on the development of new high-affinity responses to CoV2 antigenic viral variants, needs to be better understood given the need for continuous vaccine adaptation and application in the population. Due in part to thymic involution, normal aging is associated with reduced na&#xef;ve T cell compartments and impaired primary antigen responsiveness, resulting in a reliance on the pre-existing cross-reactive memory cell pool which may be of lower affinity, restricted in diversity, or of shorter duration. These effects can also be mediated by the presence of down-regulatory anti-idiotype responses which also increase in aging. Given the tremendous heterogeneity of clinical data, utilization of preclinical models offers the greatest ability to assess immune responses under a controlled setting. These models should now involve prior antigen/viral exposure combined with incorporation of modifying factors such as age on immune responses and effects. This will also allow for mechanistic dissection and understanding of the different immune pathways involved in both SARS-CoV-2 pathogen and potential vaccine responses over time and how pre-existing memory responses, including potential anti-idiotype responses, can affect efficacy as well as potential off-target effects in different tissues as well as modeling PASC.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Collins, Longo and Murphy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Craig P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Graduate Program in Immunology, University of California (UC) Davis, Davis, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Dan L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>William J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Departments of Dermatology and Internal Medicine (Hematology/Oncology), University of California (UC) Davis School of Medicine, Sacramento, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007130">Immunoglobulin Idiotypes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007130" MajorTopicYN="N">Immunoglobulin Idiotypes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">anti-idiotype antibodies</Keyword><Keyword MajorTopicYN="N">immunology</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>12</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38469293</ArticleId><ArticleId IdType="pmc">PMC10925677</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1345499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. (2020) 41:1100&#x2013;15. doi:&#xa0;10.1016/j.it.2020.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. . Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PloS One. (2021) 16:e0247461. doi:&#xa0;10.1371/journal.pone.0247461</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P, Stahel VP. Correction to: The safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg. (2021) 15:22. doi:&#xa0;10.1186/s13037-021-00296-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13037-021-00296-4</ArticleId><ArticleId IdType="pmc">PMC8130782</ArticleId><ArticleId IdType="pubmed">34006292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y-C, Cheng Y-W, Chao C-H, Chang Y-Y, Chen C-D, Tsai W-J, et al. . Antigenic cross-reactivity between SARS-CoV-2 S1-RBD and its receptor ACE2. Front Immunol. (2022) 13:868724. doi:&#xa0;10.3389/fimmu.2022.868724</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.868724</ArticleId><ArticleId IdType="pmc">PMC9114768</ArticleId><ArticleId IdType="pubmed">35603169</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. (2023) 76:e487&#x2013;90. doi:&#xa0;10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T, et al. . Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U.S.A. (2008) 105:7809&#x2013;14. doi:&#xa0;10.1073/pnas.0711241105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0711241105</ArticleId><ArticleId IdType="pmc">PMC2409424</ArticleId><ArticleId IdType="pubmed">18490652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossato A, Tessari R, Trabucchi C, Zuppini T, Realdon N, Marchesini F. Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021. Eur J Hosp Pharm. (2023) 30:e15. doi:&#xa0;10.1136/ejhpharm-2021-002933</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ejhpharm-2021-002933</ArticleId><ArticleId IdType="pmc">PMC8318724</ArticleId><ArticleId IdType="pubmed">34315774</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeet Kaur R, Dutta S, Charan J, Bhardwaj P, Tandon A, Yadav D, et al. . Cardiovascular adverse events reported from COVID-19 vaccines: A study based on WHO database. Int J Gen Med. (2021) 14:3909&#x2013;27. doi:&#xa0;10.2147/IJGM.S324349</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S324349</ArticleId><ArticleId IdType="pmc">PMC8326931</ArticleId><ArticleId IdType="pubmed">34349544</ArticleId></ArticleIdList></Reference><Reference><Citation>Minhas AS, Shade JK, Cho S-M, Michos ED, Metkus T, Gilotra NA, et al. . The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19. Int J Cardiol. (2021) 337:127&#x2013;31. doi:&#xa0;10.1016/j.ijcard.2021.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.05.011</ArticleId><ArticleId IdType="pmc">PMC8106202</ArticleId><ArticleId IdType="pubmed">33974962</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Monami M, Gori D, Guaraldi F. COVID-19 vaccine hesitancy and early adverse events reported in a cohort of 7,881 italian physicians. ANNALI DI IGIENE MED PREVENTIVA E DI COMUNIT&#xc0;. (2021) 34(4):344&#x2013;57. doi:&#xa0;10.7416/ai.2021.2491</Citation><ArticleIdList><ArticleId IdType="doi">10.7416/ai.2021.2491</ArticleId><ArticleId IdType="pubmed">34821928</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaert TM, Dinant GJ, Aretz K, Masurel N, Sprenger MJ, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. (1993) 307:988&#x2013;90. doi:&#xa0;10.1136/bmj.307.6910.988</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.307.6910.988</ArticleId><ArticleId IdType="pmc">PMC1679213</ArticleId><ArticleId IdType="pubmed">8241913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues D, de Cassia de Marchi Bacellos de Dalri R. Eventos adversos p&#xf3;s-vacina&#xe7;&#xe3;o contra influenza em idosos no Brasil/Adverse events following immunization against influenza the in elderly in Brazil. Rev Sal&#xfa;d Publica. (2019) 21:22&#x2013;8. doi:&#xa0;10.15446/rsap.v21n1.77308</Citation><ArticleIdList><ArticleId IdType="doi">10.15446/rsap.v21n1.77308</ArticleId><ArticleId IdType="pubmed">33206922</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudjedi A, Allali A, Bekli A, Lounis M, Ben Saad H, Boukoufa M. Reported COVID-19 vaccines side effects among Algerian athletes: a comparison between inactivated virus, adenoviral vector, and mRNA COVID-19 vaccines. Phys Sportsmed. (2023), 1&#x2013;13. doi:&#xa0;10.1080/00913847.2023.2186691</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00913847.2023.2186691</ArticleId><ArticleId IdType="pubmed">36876437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouhpayeh H, Ansari H. Adverse events following COVID-19 vaccination: A systematic review and meta-analysis. Int Immunopharmacol. (2022) 109:108906. doi:&#xa0;10.1016/j.intimp.2022.108906</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.108906</ArticleId><ArticleId IdType="pmc">PMC9148928</ArticleId><ArticleId IdType="pubmed">35671640</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A, Merrick B, Edgeworth J, Mandal G, Srivastava DP, Vernon AC, et al. . Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms. Mol Psychiatry. (2022) 27:5049&#x2013;61. doi:&#xa0;10.1038/s41380-022-01741-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01741-1</ArticleId><ArticleId IdType="pmc">PMC9763123</ArticleId><ArticleId IdType="pubmed">36195636</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J-H, Yang M-S, Kim D-M, Kim B, Tark D, Kang S-M, et al. . Delta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice. Sci Rep. (2023) 13:3303. doi:&#xa0;10.1038/s41598-023-29909-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-29909-x</ArticleId><ArticleId IdType="pmc">PMC9970970</ArticleId><ArticleId IdType="pubmed">36849513</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, et al. . SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Trans Med. (2022) 14:eabq3059. doi:&#xa0;10.1126/scitranslmed.abq3059</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell KL, Waickman AT. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection. Curr Opin Immunol. (2022) 77:102228. doi:&#xa0;10.1016/j.coi.2022.102228</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2022.102228</ArticleId><ArticleId IdType="pmc">PMC9127180</ArticleId><ArticleId IdType="pubmed">35724449</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz EA, Amarilla AA, Modhiran N, Parker S, Li XX, Wijesundara DK, et al. . SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol Psychiatry. (2022) 28(7):2878&#x2013;93. doi:&#xa0;10.1038/s41380-022-01831-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, et al. . SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice. Cell Rep. (2023) 42:112189. doi:&#xa0;10.1016/j.celrep.2023.112189</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.112189</ArticleId><ArticleId IdType="pmc">PMC9935273</ArticleId><ArticleId IdType="pubmed">36857178</ArticleId></ArticleIdList></Reference><Reference><Citation>
In rare cases, coronavirus vaccines may cause Long Covid&#x2013;like symptoms . Available online at: https://www.science.org/content/article/rare-cases-coronavirus-vaccines-may-cause-long-covid-symptoms.</Citation></Reference><Reference><Citation>Choe PG, Kang CK, Suh HJ, Jung J, Song K-H, Bang JH, et al. . Waning antibody responses in asymptomatic and symptomatic SARS-coV-2 infection. Emerg Infect Dis. (2021) 27:327&#x2013;9. doi:&#xa0;10.3201/eid2701.203515</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2701.203515</ArticleId><ArticleId IdType="pmc">PMC7774548</ArticleId><ArticleId IdType="pubmed">33050983</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Wang W, Ma J, Wu S, Sun F. Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis. Chin Med J (Engl). (2022) 135:145&#x2013;52. doi:&#xa0;10.1097/CM9.0000000000001892</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000001892</ArticleId><ArticleId IdType="pmc">PMC8769121</ArticleId><ArticleId IdType="pubmed">34908003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhre JS, Pongracz T, K&#xfc;nsting I, Lixenfeld AS, Wang W, Nouta J, et al. . mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Front Immunol. (2022) 13:1020844. doi:&#xa0;10.3389/fimmu.2022.1020844</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1020844</ArticleId><ArticleId IdType="pmc">PMC9877300</ArticleId><ArticleId IdType="pubmed">36713457</ArticleId></ArticleIdList></Reference><Reference><Citation>Juno JA, Tan H-X, Lee WS, Reynaldi A, Kelly HG, Wragg K, et al. . Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. (2020) 26:1428&#x2013;34. doi:&#xa0;10.1038/s41591-020-0995-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0995-0</ArticleId><ArticleId IdType="pubmed">32661393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiszel P, S&#xed;k P, Mikl&#xf3;s J, Kajd&#xe1;csi E, Sinkovits G, Cervenak L, et al. . Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history. Sci Rep. (2023) 13:13166. doi:&#xa0;10.1038/s41598-023-40103-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40103-x</ArticleId><ArticleId IdType="pmc">PMC10423719</ArticleId><ArticleId IdType="pubmed">37574522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J Immunol. (2004) 172:2731&#x2013;8. doi:&#xa0;10.4049/jimmunol.172.5.2731</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.5.2731</ArticleId><ArticleId IdType="pubmed">14978070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol. (2012) 49:32&#x2013;43. doi:&#xa0;10.1177/0300985811429314</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985811429314</ArticleId><ArticleId IdType="pubmed">22135019</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton SE, Badovinac VP, Beura LK, Pierson M, Jameson SC, Masopust D, et al. . New insights into the immune system using dirty mice. J Immunol. (2020) 205:3&#x2013;11. doi:&#xa0;10.4049/jimmunol.2000171</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000171</ArticleId><ArticleId IdType="pmc">PMC7316151</ArticleId><ArticleId IdType="pubmed">32571979</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. . Structural basis of receptor recognition by SARS-CoV-2. Nature. (2020) 581:221&#x2013;4. doi:&#xa0;10.1038/s41586-020-2179-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. (2005) 309:1864&#x2013;8. doi:&#xa0;10.1126/science.1116480</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1116480</ArticleId><ArticleId IdType="pubmed">16166518</ArticleId></ArticleIdList></Reference><Reference><Citation>Corleis B, Bastian M, Hoffmann D, Beer M, Dorhoi A. Animal models for COVID-19 and tuberculosis. Front Immunol. (2023) 14:1223260. doi:&#xa0;10.3389/fimmu.2023.1223260</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1223260</ArticleId><ArticleId IdType="pmc">PMC10451089</ArticleId><ArticleId IdType="pubmed">37638020</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanan UB, Namachivayam M, Jeewon R, Huang J-D, Durairajan SSK. Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation. World J Virol. (2022) 11:40&#x2013;56. doi:&#xa0;10.5501/wjv.v11.i1.40</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i1.40</ArticleId><ArticleId IdType="pmc">PMC8788210</ArticleId><ArticleId IdType="pubmed">35117970</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A, Paddock C, Vogel L, Butler E, Zaki S, Subbarao K. Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans. J Virol. (2005) 79:5833&#x2013;8. doi:&#xa0;10.1128/jvi.79.9.5833-5838.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.79.9.5833-5838.2005</ArticleId><ArticleId IdType="pmc">PMC1082763</ArticleId><ArticleId IdType="pubmed">15827197</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, et al. . Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol. (2009) 83:7062&#x2013;74. doi:&#xa0;10.1128/JVI.00127-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00127-09</ArticleId><ArticleId IdType="pmc">PMC2704758</ArticleId><ArticleId IdType="pubmed">19420084</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda-Okubo Y, Barnard D, Ong CH, Peng B-H, Tseng C-TK, Petrovsky N. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol. (2015) 89:2995&#x2013;3007. doi:&#xa0;10.1128/JVI.02980-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02980-14</ArticleId><ArticleId IdType="pmc">PMC4337527</ArticleId><ArticleId IdType="pubmed">25520500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng C-T, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, et al. . Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PloS One. (2012) 7:e35421. doi:&#xa0;10.1371/journal.pone.0035421</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035421</ArticleId><ArticleId IdType="pmc">PMC3335060</ArticleId><ArticleId IdType="pubmed">22536382</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata-Yoshikawa N, Nagata N, Takaki H, Matsumoto M, Suzuki T, Hasegawa H, et al. . Prophylactic vaccine targeting TLR3 on dendritic cells ameliorates eosinophilic pneumonia in a mouse SARS-coV infection model. Immunohorizons. (2022) 6:275&#x2013;82. doi:&#xa0;10.4049/immunohorizons.2200020</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2200020</ArticleId><ArticleId IdType="pubmed">35477682</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, et al. . Effects of toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine. J Virol. (2014) 88:8597&#x2013;614. doi:&#xa0;10.1128/JVI.00983-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00983-14</ArticleId><ArticleId IdType="pmc">PMC4135953</ArticleId><ArticleId IdType="pubmed">24850731</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolles M, Deming D, Long K, Agnihothram S, Whitmore A, Ferris M, et al. . A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol. (2011) 85:12201&#x2013;15. doi:&#xa0;10.1128/JVI.06048-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06048-11</ArticleId><ArticleId IdType="pmc">PMC3209347</ArticleId><ArticleId IdType="pubmed">21937658</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Chen Y, Zhao Y, Lung DC, Ye Z, Song W, et al. . Intravenous injection of coronavirus disease 2019 (COVID-19) mRNA vaccine can induce acute myopericarditis in mouse model. Clin Infect Dis. (2021) 74:1933&#x2013;50. doi:&#xa0;10.1093/cid/ciab707</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab707</ArticleId><ArticleId IdType="pmc">PMC8436386</ArticleId><ArticleId IdType="pubmed">34406358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CS, Macatonia SE, O&#x2019;Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro . J Exp Med. (1995) 181:713&#x2013;21. doi:&#xa0;10.1084/jem.181.2.713</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.181.2.713</ArticleId><ArticleId IdType="pmc">PMC2191880</ArticleId><ArticleId IdType="pubmed">7836924</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata-Yoshikawa N, Shiwa N, Sekizuka T, Sano K, Ainai A, Hemmi T, et al. . A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection. Sci Adv. (2022) 8:eabh3827. doi:&#xa0;10.1126/sciadv.abh3827</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh3827</ArticleId><ArticleId IdType="pmc">PMC8741184</ArticleId><ArticleId IdType="pubmed">34995117</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. . Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-coV-2 infection by age and sex. Circulation. (2022) 146:743&#x2013;54. doi:&#xa0;10.1161/CIRCULATIONAHA.122.059970</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059970</ArticleId><ArticleId IdType="pmc">PMC9439633</ArticleId><ArticleId IdType="pubmed">35993236</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray PB, Pewe L, Wohlford-Lenane C, Hickey M, Manzel L, Shi L, et al. . Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. (2007) 81:813&#x2013;21. doi:&#xa0;10.1128/jvi.02012-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau GB, Burgess SL, Sturek JM, Donlan AN, Petri WA, Mann BJ. Evaluation of K18-hACE2 mice as a model of SARS-coV-2 infection. Am J Trop Med Hyg. (2020) 103:1215&#x2013;9. doi:&#xa0;10.4269/ajtmh.20-0762</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0762</ArticleId><ArticleId IdType="pmc">PMC7470527</ArticleId><ArticleId IdType="pubmed">32723427</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladunni FS, Park J-G, Pino PA, Gonzalez O, Akhter A, Allu&#xe9;-Guardia A, et al. . Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice. Nat Commun. (2020) 11:6122. doi:&#xa0;10.1038/s41467-020-19891-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19891-7</ArticleId><ArticleId IdType="pmc">PMC7705712</ArticleId><ArticleId IdType="pubmed">33257679</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, et al. . SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. (2020) 21:1327&#x2013;35. doi:&#xa0;10.1038/s41590-020-0778-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Deng W, Huang B, Gao H, Liu J, Ren L, et al. . The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. (2020) 583:830&#x2013;3. doi:&#xa0;10.1038/s41586-020-2312-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2312-y</ArticleId><ArticleId IdType="pubmed">32380511</ArticleId></ArticleIdList></Reference><Reference><Citation>Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, et al. . Neuroinvasion and neurotropism by SARS-coV-2 variants in the K18-hACE2 mouse. Viruses. (2022) 14:1020. doi:&#xa0;10.3390/v14051020</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051020</ArticleId><ArticleId IdType="pmc">PMC9146514</ArticleId><ArticleId IdType="pubmed">35632761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P, Rothan HA, Natekar JP, Stone S, Pathak H, Strate PG, et al. . Neuroinvasion and encephalitis following intranasal inoculation of SARS-coV-2 in K18-hACE2 mice. Viruses. (2021) 13:132. doi:&#xa0;10.3390/v13010132</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli V, Rav&#xe0; M, Marotta D, Di Lucia P, Laura C, Sala E, et al. . Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci Immunol. (2021) 7:eabl9929. doi:&#xa0;10.1126/sciimmunol.abl9929</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl9929</ArticleId><ArticleId IdType="pmc">PMC9835999</ArticleId><ArticleId IdType="pubmed">34812647</ArticleId></ArticleIdList></Reference><Reference><Citation>Carossino M, Montanaro P, O&#x2019;Connell A, Kenney D, Gertje H, Grosz KA, et al. . Fatal neuroinvasion and SARS-CoV-2 tropism in K18-hACE2 mice is partially independent on hACE2 expression. Cold Spring Harbor Laboratory, 1 Bungtown Rd, Cold Spring Harbor, NY 11724: Preprint at bioRxiv; (2021). doi:&#xa0;10.1101/2021.01.13.425144</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.13.425144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying B, Whitener B, VanBlargan LA, Hassan AO, Shrihari S, Liang C-Y, et al. . Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Sci Trans Med. (2021) 14:eabm3302. doi:&#xa0;10.1126/scitranslmed.abm3302</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm3302</ArticleId><ArticleId IdType="pmc">PMC8817234</ArticleId><ArticleId IdType="pubmed">34846168</ArticleId></ArticleIdList></Reference><Reference><Citation>van Oosten L, Yan K, Rawle DJ, Le TT, Altenburg JJ, Fougeroux C, et al. . An S1-nanoparticle vaccine protects against SARS-coV-2 challenge in K18-hACE2 mice. J Virol. (2022) 96:e00844&#x2013;22. doi:&#xa0;10.1128/jvi.00844-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00844-22</ArticleId><ArticleId IdType="pmc">PMC9327679</ArticleId><ArticleId IdType="pubmed">35766489</ArticleId></ArticleIdList></Reference><Reference><Citation>Arieta CM, Xie YJ, Rothenberg DA, Diao H, Harjanto D, Meda S, et al. . The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. Cell. (2023) 186:2392&#x2013;2409.e21. doi:&#xa0;10.1016/j.cell.2023.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.04.007</ArticleId><ArticleId IdType="pmc">PMC10099181</ArticleId><ArticleId IdType="pubmed">37164012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying B, Scheaffer SM, Whitener B, Liang C-Y, Dmytrenko O, Mackin S, et al. . Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice. Cold Spring Harbor Laboratory, 1 Bungtown Rd, Cold Spring Harbor, NY 11724: Preprint at bioRxiv; (2022). doi:&#xa0;10.1101/2022.02.07.479419</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.07.479419</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheaffer SM, Lee D, Whitener B, Ying B, Wu K, Liang C-Y, et al. . Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice. Nat Med. (2023) 29:247&#x2013;57. doi:&#xa0;10.1038/s41591-022-02092-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02092-8</ArticleId><ArticleId IdType="pubmed">36265510</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ltgen K, Nielsen SCA, Arunachalam PS, Yang F, Hoh RA, Wirz OF, et al. . mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition. medRxiv. (2021). doi:&#xa0;10.1101/2021.04.05.21254952</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.05.21254952</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu M, Yang YJ, Johnston CD, Murphy EA, Ketas TJ, Diaz-Tapia R, et al. . Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons. Am J Obstet Gynecol MFM. (2023) 5:100796. doi:&#xa0;10.1016/j.ajogmf.2022.100796</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2022.100796</ArticleId><ArticleId IdType="pmc">PMC9626404</ArticleId><ArticleId IdType="pubmed">36334723</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Dominguez D, Henry C, Ma L, Jani H, Amato NJ, Manning T, et al. . Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice. Front Immunol. (2022) 13. doi:&#xa0;10.3389/fimmu.2022.948335</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.948335</ArticleId><ArticleId IdType="pmc">PMC9679967</ArticleId><ArticleId IdType="pubmed">36426367</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Zhang C, Yang S, Xiao W, Zheng Q, Song X. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2. J Controlled Release. (2021) 335:449&#x2013;56. doi:&#xa0;10.1016/j.jconrel.2021.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2021.05.024</ArticleId><ArticleId IdType="pmc">PMC8139338</ArticleId><ArticleId IdType="pubmed">34029632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebre MS, Rauch S, Roth N, Gergen J, Yu J, Liu X, et al. . mRNA vaccines induce rapid antibody responses in mice. NPJ Vaccines. (2022) 7:1&#x2013;7. doi:&#xa0;10.1038/s41541-022-00511-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00511-y</ArticleId><ArticleId IdType="pmc">PMC9340693</ArticleId><ArticleId IdType="pubmed">35915094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnewski AV, Luna JC, Redlich CA. Human IgG and IgA responses to COVID-19 mRNA vaccines. PloS One. (2021) 16:e0249499. doi:&#xa0;10.1371/journal.pone.0249499</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249499</ArticleId><ArticleId IdType="pmc">PMC8208542</ArticleId><ArticleId IdType="pubmed">34133415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Manso S, Alonso R, Catal&#xe1;n P, S&#xe1;nchez-Arcilla I, Marzola M, Correa-Rocha R, et al. . IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study. Front Cell Infect Microbiol. (2022) 12:1035155. doi:&#xa0;10.3389/fcimb.2022.1035155</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1035155</ArticleId><ArticleId IdType="pmc">PMC9748346</ArticleId><ArticleId IdType="pubmed">36530428</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Ji K, Tian S, Wang F, Huang B, Tong Z, et al. . A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nat Commun. (2021) 12:776. doi:&#xa0;10.1038/s41467-021-21037-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21037-2</ArticleId><ArticleId IdType="pmc">PMC7858593</ArticleId><ArticleId IdType="pubmed">33536425</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-Q, Zhang Z-R, Zhang H-Q, Zhang Y-N, Zeng X-Y, Zhang Q-Y, et al. . Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice. Sig Transduct Target Ther. (2021) 6:1&#x2013;8. doi:&#xa0;10.1038/s41392-021-00783-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00783-1</ArticleId><ArticleId IdType="pmc">PMC8543430</ArticleId><ArticleId IdType="pubmed">34697295</ArticleId></ArticleIdList></Reference><Reference><Citation>Denis J, Garnier A, Cheutin L, Ferrier A, Timera H, Jarjaval F, et al. . Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders. Front Immunol. (2023) 14:1140714. doi:&#xa0;10.3389/fimmu.2023.1140714</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1140714</ArticleId><ArticleId IdType="pmc">PMC10031022</ArticleId><ArticleId IdType="pubmed">36969158</ArticleId></ArticleIdList></Reference><Reference><Citation>Americo JL, Cotter CA, Earl PL, Liu R, Moss B. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection. Proc Natl Acad Sci U.S.A. (2022) 119:e2202069119. doi:&#xa0;10.1073/pnas.2202069119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2202069119</ArticleId><ArticleId IdType="pmc">PMC9214525</ArticleId><ArticleId IdType="pubmed">35679343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapuente D, Fuchs J, Willar J, Vieira Ant&#xe3;o A, Eberlein V, Uhlig N, et al. . Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat Commun. (2021) 12:6871. doi:&#xa0;10.1038/s41467-021-27063-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27063-4</ArticleId><ArticleId IdType="pmc">PMC8626513</ArticleId><ArticleId IdType="pubmed">34836955</ArticleId></ArticleIdList></Reference><Reference><Citation>Joag V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, Dileepan T, Soerens AG, et al. . Cutting edge: mouse SARS-coV-2 epitope reveals infection and vaccine-elicited CD8 T cell responses. J Immunol. (2021) 206:931&#x2013;5. doi:&#xa0;10.4049/jimmunol.2001400</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2001400</ArticleId><ArticleId IdType="pmc">PMC8136468</ArticleId><ArticleId IdType="pubmed">33441437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang Z, Lai X, Sun J, Chen Z, Zhang Z, Dai J, et al. . Mapping and role of T cell response in SARS-CoV-2-infected mice. J Exp Med. (2021) 218:e20202187. doi:&#xa0;10.1084/jem.20202187</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202187</ArticleId><ArticleId IdType="pmc">PMC7814348</ArticleId><ArticleId IdType="pubmed">33464307</ArticleId></ArticleIdList></Reference><Reference><Citation>Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in K18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. (2021) 321:L477&#x2013;84. doi:&#xa0;10.1152/ajplung.00223.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00223.2021</ArticleId><ArticleId IdType="pmc">PMC8384477</ArticleId><ArticleId IdType="pubmed">34156871</ArticleId></ArticleIdList></Reference><Reference><Citation>Syenina A, Gan ES, Toh JZN, Alwis R, Lin LZ, Tham CYL, et al. . Adverse effects following anti&#x2013;COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes. PloS Biol. (2022) 20:e3001643. doi:&#xa0;10.1371/journal.pbio.3001643</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001643</ArticleId><ArticleId IdType="pmc">PMC9154185</ArticleId><ArticleId IdType="pubmed">35639676</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasinghe SVW, Ku N-O, Altshuler PJ, Kwan R, Omary MB. Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity. J Cell Sci. (2014) 127:1464&#x2013;75. doi:&#xa0;10.1242/jcs.138479</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.138479</ArticleId><ArticleId IdType="pmc">PMC3970558</ArticleId><ArticleId IdType="pubmed">24463813</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W, Mead H, Tian L, Park J-G, Garcia JI, Jaramillo S, et al. . The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-coV-2 virus. J Virol. (2022) 96:e0096421. doi:&#xa0;10.1128/JVI.00964-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00964-21</ArticleId><ArticleId IdType="pmc">PMC8754221</ArticleId><ArticleId IdType="pubmed">34668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Chen RE, Alam F, Yildiz S, Case JB, Uccellini MB, et al. . SARS-coV-2 causes lung infection without severe disease in human ACE2 knock-in mice. J Virol. (2022) 96:e01511&#x2013;21. doi:&#xa0;10.1128/JVI.01511-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01511-21</ArticleId><ArticleId IdType="pmc">PMC8754206</ArticleId><ArticleId IdType="pubmed">34668780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruter AV, Korshunova DS, Kubekina MV, Sergiev PV, Kalinina AA, Ilchuk LA, et al. . Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis. Transgenic Res. (2021) 30:289&#x2013;301. doi:&#xa0;10.1007/s11248-021-00249-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-021-00249-8</ArticleId><ArticleId IdType="pmc">PMC8045570</ArticleId><ArticleId IdType="pubmed">33855640</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathnasinghe R, Strohmeier S, Amanat F, Gillespie VL, Krammer F, Garc&#xed;a-Sastre A, et al. . Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect. (2020) 9:2433&#x2013;45. doi:&#xa0;10.1080/22221751.2020.1838955</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1838955</ArticleId><ArticleId IdType="pmc">PMC7655046</ArticleId><ArticleId IdType="pubmed">33073694</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, et al. . A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PloS Pathog. (2007) 3:e5. doi:&#xa0;10.1371/journal.ppat.0030005</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0030005</ArticleId><ArticleId IdType="pmc">PMC1769406</ArticleId><ArticleId IdType="pubmed">17222058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Shuai L, Wang C, Liu R, He X, Zhang X, et al. . Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein Cell. (2020) 11:776&#x2013;82. doi:&#xa0;10.1007/s13238-020-00767-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00767-x</ArticleId><ArticleId IdType="pmc">PMC7401472</ArticleId><ArticleId IdType="pubmed">32749592</ArticleId></ArticleIdList></Reference><Reference><Citation>Leist SR, Dinnon KH, Sch&#xe4;fer A, Tse LV, Okuda K, Hou YJ, et al. . A mouse-adapted SARS-coV-2 induces acute lung injury and mortality in standard laboratory mice. Cell. (2020) 183:1070&#x2013;1085.e12. doi:&#xa0;10.1016/j.cell.2020.09.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.050</ArticleId><ArticleId IdType="pmc">PMC7510428</ArticleId><ArticleId IdType="pubmed">33031744</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnon KH, Leist SR, Sch&#xe4;fer A, Edwards CE, Martinez DR, Montgomery SA, et al. . A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature. (2020) 586:560&#x2013;6. doi:&#xa0;10.1038/s41586-020-2708-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2708-8</ArticleId><ArticleId IdType="pmc">PMC8034761</ArticleId><ArticleId IdType="pubmed">32854108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu H, Chen Q, Yang G, He L, Fan H, Deng Y-Q, et al. . Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. (2020) 369:1603&#x2013;7. doi:&#xa0;10.1126/science.abc4730</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc4730</ArticleId><ArticleId IdType="pmc">PMC7574913</ArticleId><ArticleId IdType="pubmed">32732280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N-N, Li X-F, Deng Y-Q, Zhao H, Huang Y-J, Yang G, et al. . A Thermostable mRNA Vaccine against COVID-19. Cell. (2020) 182:1271&#x2013;1283.e16. doi:&#xa0;10.1016/j.cell.2020.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.024</ArticleId><ArticleId IdType="pmc">PMC7377714</ArticleId><ArticleId IdType="pubmed">32795413</ArticleId></ArticleIdList></Reference><Reference><Citation>DiPiazza AT, Leist SR, Abiona OM, Moliva JI, Werner A, Minai M, et al. . COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity. (2021) 54:1869&#x2013;1882.e6. doi:&#xa0;10.1016/j.immuni.2021.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.018</ArticleId><ArticleId IdType="pmc">PMC8249710</ArticleId><ArticleId IdType="pubmed">34270939</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Hu G, Wang Y, Ren W, Zhao X, Ji F, et al. . Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. Proc Natl Acad Sci U.S.A. (2021) 118:e2025373118. doi:&#xa0;10.1073/pnas.2025373118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2025373118</ArticleId><ArticleId IdType="pmc">PMC8000431</ArticleId><ArticleId IdType="pubmed">33658332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-N, Zhang Z-R, Zhang H-Q, Li N, Zhang Q-Y, Li X-D, et al. . Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters. Sig Transduct Target Ther. (2022) 7:1&#x2013;3. doi:&#xa0;10.1038/s41392-022-00930-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00930-2</ArticleId><ArticleId IdType="pmc">PMC8873353</ArticleId><ArticleId IdType="pubmed">35217641</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterrieder N, Bertzbach LD, Dietert K, Abdelgawad A, Vladimirova D, Kunec D, et al. . Age-dependent progression of SARS-coV-2 infection in Syrian hamsters. Viruses. (2020) 12:779. doi:&#xa0;10.3390/v12070779</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12070779</ArticleId><ArticleId IdType="pmc">PMC7412213</ArticleId><ArticleId IdType="pubmed">32698441</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M, Iwatsuki-Horimoto K, Hatta M, Loeber S, Halfmann PJ, Nakajima N, et al. . Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc Natl Acad Sci U.S.A. (2020) 117:16587&#x2013;95. doi:&#xa0;10.1073/pnas.2009799117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Kornau H-C, S&#xe1;nchez-Sendin E, Corman VM, Liu H, et al. . A therapeutic non-self-reactive SARS-coV-2 antibody protects from lung pathology in a COVID-19 hamster model. Cell. (2020) 183:1058&#x2013;1069.e19. doi:&#xa0;10.1016/j.cell.2020.09.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.049</ArticleId><ArticleId IdType="pmc">PMC7510528</ArticleId><ArticleId IdType="pubmed">33058755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieber CM, Cox RM, Sourimant J, Wolf JD, Juergens K, Phung Q, et al. . SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model. Nat Commun. (2022) 13:4416. doi:&#xa0;10.1038/s41467-022-32045-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32045-1</ArticleId><ArticleId IdType="pmc">PMC9338273</ArticleId><ArticleId IdType="pubmed">35906230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee AC-Y, Chu H, Chan JF-W, Fan Z, Li C, et al. . SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters. Clin Infect Dis. (2020) 73(2):e503&#x2013;12. doi:&#xa0;10.1093/cid/ciaa995</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa995</ArticleId><ArticleId IdType="pmc">PMC7454453</ArticleId><ArticleId IdType="pubmed">32667973</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini RA, Frere JJ, Zimering J, Giosan IM, Pryce KD, Golynker I, et al. . SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model. Sci Signaling. (2023) 16:eade4984. doi:&#xa0;10.1126/scisignal.ade4984</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.ade4984</ArticleId><ArticleId IdType="pmc">PMC10422867</ArticleId><ArticleId IdType="pubmed">37159520</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydemann L, Ciurkiewicz M, Beythien G, Becker K, Schughart K, Stanelle-Bertram S, et al. . Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2. Nat Commun. (2023) 14:3267. doi:&#xa0;10.1038/s41467-023-39049-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39049-5</ArticleId><ArticleId IdType="pmc">PMC10241385</ArticleId><ArticleId IdType="pubmed">37277327</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi S, Oishi K, Carrau L, Frere J, M&#xf8;ller R, Panis M, et al. . Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission. Sci Immunol. (2021) 6:eabm3131. doi:&#xa0;10.1126/sciimmunol.abm3131</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm3131</ArticleId><ArticleId IdType="pubmed">34699266</ArticleId></ArticleIdList></Reference><Reference><Citation>Field CJ, Heinly TA, Patel DR, Sim DG, Luley E, Gupta SL, et al. . Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters. Emerg Microbes Infect. (2022) 11:1103&#x2013;14. doi:&#xa0;10.1080/22221751.2022.2058419</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2058419</ArticleId><ArticleId IdType="pmc">PMC9037228</ArticleId><ArticleId IdType="pubmed">35333692</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, et al. . Are hamsters a suitable model for evaluating the immunogenicity of RBD-based anti-COVID-19 subunit vaccines? Viruses. (2022) 14:1060. doi:&#xa0;10.3390/v14051060</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051060</ArticleId><ArticleId IdType="pmc">PMC9146860</ArticleId><ArticleId IdType="pubmed">35632800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sui Y, Andersen H, Li J, Hoang T, Bekele Y, Kar S, et al. . Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants. Front Immunol. (2023) 14:1154496. doi:&#xa0;10.3389/fimmu.2023.1154496</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1154496</ArticleId><ArticleId IdType="pmc">PMC10067881</ArticleId><ArticleId IdType="pubmed">37020550</ArticleId></ArticleIdList></Reference><Reference><Citation>Belser JA, Katz JM, Tumpey TM. The ferret as a model organism to study influenza A virus infection. Dis Model Mech. (2011) 4:575&#x2013;9. doi:&#xa0;10.1242/dmm.007823</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.007823</ArticleId><ArticleId IdType="pmc">PMC3180220</ArticleId><ArticleId IdType="pubmed">21810904</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Wang A, Wang L, Wang B, Tian G, Yang J, et al. . Systematic tracing of susceptible animals to SARS-coV-2 by a bioinformatics framework. Front Microbiol. (2022) 13:781770. doi:&#xa0;10.3389/fmicb.2022.781770</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.781770</ArticleId><ArticleId IdType="pmc">PMC8931700</ArticleId><ArticleId IdType="pubmed">35308363</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard M, Kok A, de Meulder D, Bestebroer TM, Lamers MM, Okba NMA, et al. . SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat Commun. (2020) 11:3496. doi:&#xa0;10.1038/s41467-020-17367-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17367-2</ArticleId><ArticleId IdType="pmc">PMC7343828</ArticleId><ArticleId IdType="pubmed">32641684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan KA, Bewley KR, Fotheringham SA, Slack GS, Brown P, Hall Y, et al. . Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat Commun. (2021) 12:81. doi:&#xa0;10.1038/s41467-020-20439-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20439-y</ArticleId><ArticleId IdType="pmc">PMC7782478</ArticleId><ArticleId IdType="pubmed">33398055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamoto A, Taguchi F, Fukushi S, Morikawa S, Yamada YK. Identification of ferret ACE2 and its receptor Function for Sars-Coronavirus. In: Perlman S, Holmes KV, editors. The Nidoviruses Advances in Experimental Medicine and Biology. One New York Plaza, Suite 4600, New York, NY 10004-1562, USA: Springer US; (2006). p. 519&#x2013;22. doi:&#xa0;10.1007/978-0-387-33012-9_93</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-33012-9_93</ArticleId><ArticleId IdType="pmc">PMC7123533</ArticleId><ArticleId IdType="pubmed">17037589</ArticleId></ArticleIdList></Reference><Reference><Citation>Au GG, Marsh GA, McAuley AJ, Lowther S, Trinidad L, Edwards S, et al. . Characterisation and natural progression of SARS-CoV-2 infection in ferrets. Sci Rep. (2022) 12:5680. doi:&#xa0;10.1038/s41598-022-08431-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08431-6</ArticleId><ArticleId IdType="pmc">PMC8981194</ArticleId><ArticleId IdType="pubmed">35383204</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen EB, Orvold SN, Swan CL, Yourkowski A, Thivierge BM, Francis ME, et al. . After the virus has cleared-Can preclinical models be employed for Long COVID research? PloS Pathog. (2022) 18:e1010741. doi:&#xa0;10.1371/journal.ppat.1010741</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010741</ArticleId><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="pubmed">36070309</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Ven K, van Dijken H, Wijsman L, Gomersbach A, Schouten T, Kool J, et al. . Pathology and immunity after SARS-coV-2 infection in male ferrets is affected by age and inoculation route. Front Immunol. (2021) 12:750229. doi:&#xa0;10.3389/fimmu.2021.750229</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.750229</ArticleId><ArticleId IdType="pmc">PMC8566349</ArticleId><ArticleId IdType="pubmed">34745122</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, et al. . Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. (2020) 368:1016&#x2013;20. doi:&#xa0;10.1126/science.abb7015</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb7015</ArticleId><ArticleId IdType="pmc">PMC7164390</ArticleId><ArticleId IdType="pubmed">32269068</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis ME, Richardson B, Goncin U, McNeil M, Rioux M, Foley MK, et al. . Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets. Sci Rep. (2021) 11:14536. doi:&#xa0;10.1038/s41598-021-93855-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93855-9</ArticleId><ArticleId IdType="pmc">PMC8282673</ArticleId><ArticleId IdType="pubmed">34267262</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu S, Zhao Y, Yu W, Yang Y, Gao J, Wang J, et al. . Comparison of nonhuman primates identified the suitable model for COVID-19. Sig Transduct Target Ther. (2020) 5:1&#x2013;9. doi:&#xa0;10.1038/s41392-020-00269-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00269-6</ArticleId><ArticleId IdType="pmc">PMC7434851</ArticleId><ArticleId IdType="pubmed">32814760</ArticleId></ArticleIdList></Reference><Reference><Citation>Munster VJ, Feldmann F, Williamson BN, van Doremalen N, P&#xe9;rez-P&#xe9;rez L, Schulz J, et al. . Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. (2020) 585:268&#x2013;72. doi:&#xa0;10.1038/s41586-020-2324-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2324-7</ArticleId><ArticleId IdType="pmc">PMC7486227</ArticleId><ArticleId IdType="pubmed">32396922</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolsey C, Borisevich V, Prasad AN, Agans KN, Deer DJ, Dobias NS, et al. . Establishment of an African green monkey model for COVID-19 and protection against re-infection. Nat Immunol. (2021) 22:86&#x2013;98. doi:&#xa0;10.1038/s41590-020-00835-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00835-8</ArticleId><ArticleId IdType="pmc">PMC7790436</ArticleId><ArticleId IdType="pubmed">33235385</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett KS, Nason MC, Flach B, Gagne M, O&#x2019;Connell S, Johnston TS, et al. . Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science. (2021) 373:eabj0299. doi:&#xa0;10.1126/science.abj0299</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj0299</ArticleId><ArticleId IdType="pmc">PMC8449013</ArticleId><ArticleId IdType="pubmed">34529476</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbett KS, Gagne M, Wagner DA, O&#x2019; Connell S, Narpala SR, Flebbe DR, et al. . Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates. Science. (2021) 374:1343&#x2013;53. doi:&#xa0;10.1126/science.abl8912</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl8912</ArticleId><ArticleId IdType="pubmed">34672695</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagne M, Moliva JI, Foulds KE, Andrew SF, Flynn BJ, Werner AP, et al. . mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron. Cell. (2022) 185:1556&#x2013;1571.e18. doi:&#xa0;10.1016/j.cell.2022.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.03.038</ArticleId><ArticleId IdType="pmc">PMC8947944</ArticleId><ArticleId IdType="pubmed">35447072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronvall G, Nordenfelt E. On the history of human coronaviruses. APMIS. (2021) 129(7):381&#x2013;3. doi:&#xa0;10.1111/apm.13109</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.13109</ArticleId><ArticleId IdType="pmc">PMC8014751</ArticleId><ArticleId IdType="pubmed">33624304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sealy RE, Hurwitz JL. Cross-reactive immune responses toward the common cold human coronaviruses and severe acute respiratory syndrome coronavirus 2 (SARS-coV-2): mini-review and a murine study. Microorganisms. (2021) 9:1643. doi:&#xa0;10.3390/microorganisms9081643</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081643</ArticleId><ArticleId IdType="pmc">PMC8398386</ArticleId><ArticleId IdType="pubmed">34442723</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SR. Forty years with coronaviruses. J Exp Med. (2020) 217:e20200537. doi:&#xa0;10.1084/jem.20200537</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200537</ArticleId><ArticleId IdType="pmc">PMC7103766</ArticleId><ArticleId IdType="pubmed">32232339</ArticleId></ArticleIdList></Reference><Reference><Citation>Riski H, Hovi T. Coronavirus infections of man associated with diseases other than the common cold. J Med Virol. (1980) 6:259&#x2013;65. doi:&#xa0;10.1002/jmv.1890060309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890060309</ArticleId><ArticleId IdType="pmc">PMC7166474</ArticleId><ArticleId IdType="pubmed">6262459</ArticleId></ArticleIdList></Reference><Reference><Citation>Killerby ME, Biggs HM, Haynes A, Dahl RM, Mustaquim D, Gerber SI, et al. . Human coronavirus circulation in the United States 2014-2017. J Clin Virol. (2018) 101:52&#x2013;6. doi:&#xa0;10.1016/j.jcv.2018.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.019</ArticleId><ArticleId IdType="pmc">PMC7106380</ArticleId><ArticleId IdType="pubmed">29427907</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. (2021) 19:155&#x2013;70. doi:&#xa0;10.1038/s41579-020-00468-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S, et al. . Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. (2020) 370:1339&#x2013;43. doi:&#xa0;10.1126/science.abe1107</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1107</ArticleId><ArticleId IdType="pmc">PMC7857411</ArticleId><ArticleId IdType="pubmed">33159009</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, et al. . Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. (2020) 370:89&#x2013;94. doi:&#xa0;10.1126/science.abd3871</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3871</ArticleId><ArticleId IdType="pmc">PMC7574914</ArticleId><ArticleId IdType="pubmed">32753554</ArticleId></ArticleIdList></Reference><Reference><Citation>Woldemeskel BA, Kwaa AK, Garliss CC, Laeyendecker O, Ray SC, Blankson JN. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2. J Clin Invest. (2020) 130:6631&#x2013;8. doi:&#xa0;10.1172/JCI143120</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143120</ArticleId><ArticleId IdType="pmc">PMC7685719</ArticleId><ArticleId IdType="pubmed">32966269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulien I, Kemming J, Oberhardt V, Wild K, Seidel LM, Killmer S, et al. . Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat Med. (2021) 27:78&#x2013;85. doi:&#xa0;10.1038/s41591-020-01143-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01143-2</ArticleId><ArticleId IdType="pubmed">33184509</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit WL, van Tol S, Haas LEM, Limonard GJM, Bossink A, Reusken C, et al. . Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19. Virol J. (2023) 20:85. doi:&#xa0;10.1186/s12985-023-02050-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02050-x</ArticleId><ArticleId IdType="pmc">PMC10156070</ArticleId><ArticleId IdType="pubmed">37138352</ArticleId></ArticleIdList></Reference><Reference><Citation>Simula ER, Manca MA, Jasemi S, Uzzau S, Rubino S, Manchia P, et al. . HCoV-NL63 and SARS-coV-2 share recognized epitopes by the humoral response in sera of people collected pre- and during coV-2 pandemic. Microorganisms. (2020) 8:1993. doi:&#xa0;10.3390/microorganisms8121993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8121993</ArticleId><ArticleId IdType="pmc">PMC7764996</ArticleId><ArticleId IdType="pubmed">33327507</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, et al. . The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol. (2023) 23:304&#x2013;16. doi:&#xa0;10.1038/s41577-022-00809-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00809-x</ArticleId><ArticleId IdType="pmc">PMC9765363</ArticleId><ArticleId IdType="pubmed">36539527</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgenlander WR, Henson SN, Monaco DR, Chen A, Littlefield K, Bloch EM, et al. . Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. J Clin Invest. (2021) 131:146927. doi:&#xa0;10.1172/JCI146927</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146927</ArticleId><ArticleId IdType="pmc">PMC8011893</ArticleId><ArticleId IdType="pubmed">33571169</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. J Infect Dis. (2020) 222:17&#x2013;25. doi:&#xa0;10.1093/infdis/jiaa185</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa185</ArticleId><ArticleId IdType="pmc">PMC7184404</ArticleId><ArticleId IdType="pubmed">32296837</ArticleId></ArticleIdList></Reference><Reference><Citation>Klompus S, Leviatan S, Vogl T, Mazor RD, Kalka IN, Stoler-Barak L, et al. . Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Sci Immunol. (2021) 6:eabe9950. doi:&#xa0;10.1126/sciimmunol.abe9950</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe9950</ArticleId><ArticleId IdType="pmc">PMC9267281</ArticleId><ArticleId IdType="pubmed">34326184</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Bretones M, Fouchier RA, Koopmans MP, van Nierop GP. Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity. J Clin Invest. (2023) 133:e162192. doi:&#xa0;10.1172/JCI162192</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI162192</ArticleId><ArticleId IdType="pmc">PMC9797340</ArticleId><ArticleId IdType="pubmed">36594464</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, et al. . SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. Cell Rep. (2022) 41:111496. doi:&#xa0;10.1016/j.celrep.2022.111496</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111496</ArticleId><ArticleId IdType="pmc">PMC9578169</ArticleId><ArticleId IdType="pubmed">36261003</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, et al. . Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol. (2003) 170:2022&#x2013;9. doi:&#xa0;10.4049/jimmunol.170.4.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.4.2022</ArticleId><ArticleId IdType="pubmed">12574372</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HS, Kim Y, Kang J, Um J, Park JS, Park WB, et al. . Longitudinal analysis of memory T-cell responses in survivors of middle east respiratory syndrome. Clin Infect Dis. (2022) 75:596&#x2013;603. doi:&#xa0;10.1093/cid/ciab1019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab1019</ArticleId><ArticleId IdType="pmc">PMC9383109</ArticleId><ArticleId IdType="pubmed">34893799</ArticleId></ArticleIdList></Reference><Reference><Citation>Taira N, Toguchi S, Miyagi M, Mori T, Tomori H, Oshiro K, et al. . Altered pre-existing SARS-CoV-2-specific T cell responses in elderly individuals. Clin Immunol Commun. (2022) 2:6&#x2013;11. doi:&#xa0;10.1016/j.clicom.2021.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clicom.2021.12.001</ArticleId><ArticleId IdType="pmc">PMC8694817</ArticleId><ArticleId IdType="pubmed">38621014</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend JP, Hassler HB, Wang Z, Miura S, Singh J, Kumar S, et al. . The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study. Lancet Microbe. (2021) 2:e666&#x2013;75. doi:&#xa0;10.1016/S2666-5247(21)00219-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00219-6</ArticleId><ArticleId IdType="pmc">PMC8486316</ArticleId><ArticleId IdType="pubmed">34632431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar M, Reifler K, Rossi M, Miller NS, Sinha P, White LF, et al. . Recent endemic coronavirus infection is associated with less-severe COVID-19. J Clin Invest. (2021) 131(1):e143380. doi:&#xa0;10.1172/JCI143380</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI143380</ArticleId><ArticleId IdType="pmc">PMC7773342</ArticleId><ArticleId IdType="pubmed">32997649</ArticleId></ArticleIdList></Reference><Reference><Citation>Reche PA. Potential cross-reactive immunity to SARS-coV-2 from common human pathogens and vaccines. Front Immunol. (2020) 11:586984. doi:&#xa0;10.3389/fimmu.2020.586984</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.586984</ArticleId><ArticleId IdType="pmc">PMC7596387</ArticleId><ArticleId IdType="pubmed">33178220</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateus J, Dan JM, Zhang Z, Rydyznski Moderbacher C, Lammers M, Goodwin B, et al. . Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science. (2021) 374:eabj9853. doi:&#xa0;10.1126/science.abj9853</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj9853</ArticleId><ArticleId IdType="pmc">PMC8542617</ArticleId><ArticleId IdType="pubmed">34519540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wratil PR, Schmacke NA, Karakoc B, Dulovic A, Junker D, Becker M, et al. . Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses. Cell Rep. (2021) 37:110169. doi:&#xa0;10.1016/j.celrep.2021.110169</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110169</ArticleId><ArticleId IdType="pmc">PMC8648802</ArticleId><ArticleId IdType="pubmed">34932974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C-Y, Wolf J, Brice DC, Sun Y, Locke M, Cherry S, et al. . Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response. Cell Host Microbe. (2022) 30:83&#x2013;96.e4. doi:&#xa0;10.1016/j.chom.2021.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8648673</ArticleId><ArticleId IdType="pubmed">34965382</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta A, Cranage M, Zipeto D. Is cross-reactive immunity triggering COVID-19 immunopathogenesis? Front Immunol. (2020) 11:567710. doi:&#xa0;10.3389/fimmu.2020.567710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.567710</ArticleId><ArticleId IdType="pmc">PMC7594548</ArticleId><ArticleId IdType="pubmed">33178193</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G, He W-T, Callaghan S, Anzanello F, Huang D, Ricketts J, et al. . Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. (2021) 12:2938. doi:&#xa0;10.1038/s41467-021-23074-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23074-3</ArticleId><ArticleId IdType="pmc">PMC8134462</ArticleId><ArticleId IdType="pubmed">34011939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KH, Cheng VCC, Woo PCY, Lau SKP, Poon LLM, Guan Y, et al. . Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol. (2005) 12:1317&#x2013;21. doi:&#xa0;10.1128/CDLI.12.11.1317-1321.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.12.11.1317-1321.2005</ArticleId><ArticleId IdType="pmc">PMC1287763</ArticleId><ArticleId IdType="pubmed">16275947</ArticleId></ArticleIdList></Reference><Reference><Citation>de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, et al. . Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nat Commun. (2021) 12:6. doi:&#xa0;10.1038/s41467-020-20095-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20095-2</ArticleId><ArticleId IdType="pmc">PMC7782488</ArticleId><ArticleId IdType="pubmed">33397903</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol. (2000) 20:250&#x2013;6. doi:&#xa0;10.1023/a:1006611518223</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1006611518223</ArticleId><ArticleId IdType="pubmed">10939712</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Dong X, Zhang Z, Zhang Q, Zhao Y. Age-related thymic involution: Mechanisms and functional impact. Aging Cell. (2022) 21:e13671. doi:&#xa0;10.1111/acel.13671</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13671</ArticleId><ArticleId IdType="pmc">PMC9381902</ArticleId><ArticleId IdType="pubmed">35822239</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. (2014) 30:16&#x2013;22. doi:&#xa0;10.3109/09513590.2013.852531</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09513590.2013.852531</ArticleId><ArticleId IdType="pubmed">24219599</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, et al. . Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. (2019) 25:141&#x2013;51. doi:&#xa0;10.1038/s41591-018-0221-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0221-5</ArticleId><ArticleId IdType="pmc">PMC6324991</ArticleId><ArticleId IdType="pubmed">30420753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Fisher EM, Murasko DM. CD8 T cell responses to influenza virus infection in aged mice. Ageing Res Rev. (2011) 10:422&#x2013;7. doi:&#xa0;10.1016/j.arr.2011.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2011.02.001</ArticleId><ArticleId IdType="pmc">PMC3640258</ArticleId><ArticleId IdType="pubmed">21315186</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-&#x17d;ugich J, Bradshaw CM, Uhrlaub JL, Watanabe M. Immunity to acute virus infections with advanced age. Curr Opin Virol. (2021) 46:45&#x2013;58. doi:&#xa0;10.1016/j.coviro.2020.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2020.09.007</ArticleId><ArticleId IdType="pmc">PMC7979450</ArticleId><ArticleId IdType="pubmed">33160186</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor K, Li G, Vallejo AN, Lee W-W, Koetz K, Bryl E, et al. . The influence of age on T cell generation and TCR diversity. J Immunol. (2005) 174:7446&#x2013;52. doi:&#xa0;10.4049/jimmunol.174.11.7446</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.11.7446</ArticleId><ArticleId IdType="pubmed">15905594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med. (2008) 205:711&#x2013;23. doi:&#xa0;10.1084/jem.20071140</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071140</ArticleId><ArticleId IdType="pmc">PMC2275391</ArticleId><ArticleId IdType="pubmed">18332179</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med. (2004) 200:1613&#x2013;22. doi:&#xa0;10.1084/jem.20041395</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20041395</ArticleId><ArticleId IdType="pmc">PMC2211991</ArticleId><ArticleId IdType="pubmed">15611289</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, et al. . B cells and aging: molecules and mechanisms. Trends Immunol. (2009) 30:313&#x2013;8. doi:&#xa0;10.1016/j.it.2009.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2009.04.005</ArticleId><ArticleId IdType="pmc">PMC2766868</ArticleId><ArticleId IdType="pubmed">19540810</ArticleId></ArticleIdList></Reference><Reference><Citation>Weksler ME, Russo C, Siskind GW. Peripheral T cells select the B-cell repertoire in old mice. Immunol Rev. (1989) 110:173&#x2013;85. doi:&#xa0;10.1111/j.1600-065x.1989.tb00033.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065x.1989.tb00033.x</ArticleId><ArticleId IdType="pubmed">2676847</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Bretones M, Westerhuis BM, Raadsen MP, de Bruin E, Chandler FD, Okba NMA, et al. . Seasonal coronavirus&#x2013;specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19. J Clin Invest. (2021) 131(21):e150613. doi:&#xa0;10.1172/JCI150613</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150613</ArticleId><ArticleId IdType="pmc">PMC8553556</ArticleId><ArticleId IdType="pubmed">34499051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacher P, Rosati E, Esser D, Martini GR, Saggau C, Schiminsky E, et al. . Low-avidity CD4+ T cell responses to SARS-coV-2 in unexposed individuals and humans with severe COVID-19. Immunity. (2020) 53:1258&#x2013;1271.e5. doi:&#xa0;10.1016/j.immuni.2020.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.11.016</ArticleId><ArticleId IdType="pmc">PMC7689350</ArticleId><ArticleId IdType="pubmed">33296686</ArticleId></ArticleIdList></Reference><Reference><Citation>Dykema AG, Zhang B, Woldemeskel BA, Garliss CC, Cheung LS, Choudhury D, et al. . Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses. J Clin Invest. (2021) 131:146922. doi:&#xa0;10.1172/JCI146922</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI146922</ArticleId><ArticleId IdType="pmc">PMC8121515</ArticleId><ArticleId IdType="pubmed">33830946</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Arndt L, Schwarz T, Loyal L, Henze L, Kruse B, Dingeldey M, et al. . Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly. J Immunol. (2022) 208:1001&#x2013;5. doi:&#xa0;10.4049/jimmunol.2100990</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100990</ArticleId><ArticleId IdType="pubmed">35121642</ArticleId></ArticleIdList></Reference><Reference><Citation>Saletti G, Gerlach T, Jansen JM, Molle A, Elbahesh H, Ludlow M, et al. . Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. Sci Rep. (2020) 10:21447. doi:&#xa0;10.1038/s41598-020-78506-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78506-9</ArticleId><ArticleId IdType="pmc">PMC7722724</ArticleId><ArticleId IdType="pubmed">33293664</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L, Andr&#xe9;e M, Ostermann PN, Jazmati N, Fl&#xfc;h G, Fischer JC, et al. . SARS-coV-2 infection in fully vaccinated individuals of old age strongly boosts the humoral immune response. Front Med. (2021) 8. doi:&#xa0;10.3389/fmed.2021.746644</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.746644</ArticleId><ArticleId IdType="pmc">PMC8544807</ArticleId><ArticleId IdType="pubmed">34708057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bag Soytas R, Cengiz M, Islamoglu MS, Borku Uysal B, Yavuzer S, Yavuzer H. Antibody responses to COVID-19 vaccines in older adults. J Med Virol. (2022) 94:1650&#x2013;4. doi:&#xa0;10.1002/jmv.27531</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27531</ArticleId><ArticleId IdType="pubmed">34921432</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowley AR, Natarajan H, Hederman AP, Bobak CA, Weiner JA, Wieland-Alter W, et al. . Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike. eLife. (2022) 11:e75228. doi:&#xa0;10.7554/eLife.75228</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75228</ArticleId><ArticleId IdType="pmc">PMC8923670</ArticleId><ArticleId IdType="pubmed">35289271</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspinall R, Lang PO. Interventions to restore appropriate immune function in the elderly. Immun Ageing. (2018) 15:5. doi:&#xa0;10.1186/s12979-017-0111-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-017-0111-6</ArticleId><ArticleId IdType="pmc">PMC5785902</ArticleId><ArticleId IdType="pubmed">29416551</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris). (1974) 125C:373&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">4142565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearney JF, Barletta R, Quan ZS, Quint&#xe1;ns J. Monoclonal vs. heterogeneous anti-H-8 antibodies in the analysis of the anti-phosphorylcholine response in BALB/c mice. Eur J Immunol. (1981) 11:877&#x2013;83. doi:&#xa0;10.1002/eji.1830111106</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830111106</ArticleId><ArticleId IdType="pubmed">7035186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittner MK, Bach MA, K&#xf6;hler H. Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC15 antibodies. J Immunol. (1982) 128:595&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7033381</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosenza H. Detection of anti-idiotype reactive cells in the response to phosphorylcholine. Eur J Immunol. (1976) 6:114&#x2013;6. doi:&#xa0;10.1002/eji.1830060208</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830060208</ArticleId><ArticleId IdType="pubmed">1085701</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosenza H, K&#xf6;hler H. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Science. (1972) 176:1027&#x2013;9. doi:&#xa0;10.1126/science.176.4038.1027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.176.4038.1027</ArticleId><ArticleId IdType="pubmed">4113485</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbain J, Wikler M, Franssen JD, Collignon C. Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proc Natl Acad Sci. (1977) 74:5126&#x2013;30. doi:&#xa0;10.1073/pnas.74.11.5126</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.74.11.5126</ArticleId><ArticleId IdType="pmc">PMC432113</ArticleId><ArticleId IdType="pubmed">303775</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazenave PA. Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proc Natl Acad Sci. (1977) 74:5122&#x2013;5. doi:&#xa0;10.1073/pnas.74.11.5122</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.74.11.5122</ArticleId><ArticleId IdType="pmc">PMC432112</ArticleId><ArticleId IdType="pubmed">270748</ArticleId></ArticleIdList></Reference><Reference><Citation>Geha RS. Idiotypic&#x2013;anti-idiotypic interactions in man. Am J Dis Children. (1985) 139:417&#x2013;20. doi:&#xa0;10.1001/archpedi.1985.02140060099041</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpedi.1985.02140060099041</ArticleId><ArticleId IdType="pubmed">2579545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerne NK. The immune system: a web of V-domains. Harvey Lect 70 Series. Harvey Society of New York - New York City, New York: (1974). pp. 93&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">4143481</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanova AK, Ryabkova VA, Utekhin SV, Shoenfeld VJ, Churilov LP, Shoenfeld Y. Anti-idiotypic agonistic antibodies: candidates for the role of universal remedy. Antibodies (Basel). (2020) 9:E19. doi:&#xa0;10.3390/antib9020019</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib9020019</ArticleId><ArticleId IdType="pmc">PMC7345059</ArticleId><ArticleId IdType="pubmed">32481667</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy WJ, Longo DL. A possible role for anti-idiotype antibodies in SARS-coV-2 infection and vaccination. New Engl J Med. (2021) 386(4):394&#x2013;6. doi:&#xa0;10.1056/NEJMcibr2113694</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2113694</ArticleId><ArticleId IdType="pubmed">34818473</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichmann K, Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol. (1975) 5:661&#x2013;6. doi:&#xa0;10.1002/eji.1830051002</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830051002</ArticleId><ArticleId IdType="pubmed">11993330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Francois MJ, Poskitt DC, MacDonald LM, Turnbull SJ, Yasmeen D. Production of monoclonal anti-idiotype antibodies which mimic an M-like protein of Streptococcus equi. Microbiol Immunol. (1993) 37:737&#x2013;42. doi:&#xa0;10.1111/j.1348-0421.1993.tb01699.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.1993.tb01699.x</ArticleId><ArticleId IdType="pubmed">8271975</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy WJ, Collins CP, Ashwood P. Potential role of anti-Idiotype responses on the neurological effects of post-acute sequelae of COVID-19 (PASC). Brain Behav Immun. (2023) 116:317&#x2013;20. doi:&#xa0;10.1016/j.bbi.2023.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.12.017</ArticleId><ArticleId IdType="pubmed">38123027</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, Forrest JC, Boehme KW, Kennedy JL, Owens S, Herzog C, et al. . Development of ACE2 autoantibodies after SARS-CoV-2 infection. PloS One. (2021) 16:e0257016. doi:&#xa0;10.1371/journal.pone.0257016</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Maden CH, Gomes J, Schwarz Q, Davidson K, Tinker A, Ruhrberg C. NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system. Dev Biol. (2012) 369:277&#x2013;85. doi:&#xa0;10.1016/j.ydbio.2012.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2012.06.026</ArticleId><ArticleId IdType="pmc">PMC3430865</ArticleId><ArticleId IdType="pubmed">22790009</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlueter AJ, Segre D, Kuhlenschmidt MS, Segre M. Behavior of the idiotypic network in conventional immune responses: I. Kinetics of idiotypic and anti-idiotypic antibodies following immunization with T-independent and T-dependent antigens. Cell Immunol. (1992) 144:311&#x2013;23. doi:&#xa0;10.1016/0008-8749(92)90247-M</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-8749(92)90247-M</ArticleId><ArticleId IdType="pubmed">1382868</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghesi C, Nicoletti C. Increase of cross(auto)-reactive antibodies after immunization in aged mice: a cellular and molecular study. Int J Exp Pathol. (1994) 75:123&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2002101</ArticleId><ArticleId IdType="pubmed">8199004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YT, Goidl EA, Samarut C, Weksler ME, Thorbecke GJ, Siskind GW. Bone marrow function. I. Peripheral T cells are responsible for the increased auto-antiidiotype response of older mice. J Exp Med. (1985) 161:1237&#x2013;42. doi:&#xa0;10.1084/jem.161.5.1237</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.161.5.1237</ArticleId><ArticleId IdType="pmc">PMC2187606</ArticleId><ArticleId IdType="pubmed">3886829</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffery-Smith A, Burton AR, Lens S, Rees-Spear C, Davies J, Patel M, et al. . SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies. J Clin Invest. (2021) 132(2). doi:&#xa0;10.1172/JCI152042</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152042</ArticleId><ArticleId IdType="pmc">PMC8759779</ArticleId><ArticleId IdType="pubmed">34843448</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Haga S, Ishizaka Y, Mimori A. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res Ther. (2010) 12:R85. doi:&#xa0;10.1186/ar3012</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3012</ArticleId><ArticleId IdType="pmc">PMC2911869</ArticleId><ArticleId IdType="pubmed">20470389</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PloS Med. (2023) 20:e1004194. doi:&#xa0;10.1371/journal.pmed.1004194</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004194</ArticleId><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, et al. . Development of a definition of postacute sequelae of SARS-coV-2 infection. JAMA. (2023) 329:1934&#x2013;46. doi:&#xa0;10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Safavi F, Gustafson L, Walitt B, Lehky T, Dehbashi S, Wiebold A, et al. . Neuropathic symptoms with SARS-CoV-2 vaccination. medRxiv. (2022). doi:&#xa0;10.1101/2022.05.16.22274439</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.16.22274439</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Neurological adverse reactions to SARS-coV-2 vaccines. Clin Psychopharmacol Neurosci. (2023) 21:222&#x2013;39. doi:&#xa0;10.9758/cpn.2023.21.2.222</Citation><ArticleIdList><ArticleId IdType="doi">10.9758/cpn.2023.21.2.222</ArticleId><ArticleId IdType="pmc">PMC10157009</ArticleId><ArticleId IdType="pubmed">37119215</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Huang L. Neurological disorders following COVID-19 vaccination. Vaccines (Basel). (2023) 11:1114. doi:&#xa0;10.3390/vaccines11061114</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11061114</ArticleId><ArticleId IdType="pmc">PMC10302665</ArticleId><ArticleId IdType="pubmed">37376503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis SN, Durieux JC, Mouchati C, Perez JA, McComsey GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: A multicenter study from a large national health research network. Open Forum Infect Dis. (2022) 9:ofac228. doi:&#xa0;10.1093/ofid/ofac228</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Effros RB, Walford RL. The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity. Cell Immunol. (1983) 81:298&#x2013;305. doi:&#xa0;10.1016/0008-8749(83)90237-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0008-8749(83)90237-x</ArticleId><ArticleId IdType="pubmed">6605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626&#x2013;38. doi:&#xa0;10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Reidy L, Cray C, Diaz A, Romero M, Kahl K, et al. . Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients. PloS One. (2021) 16:e0245424. doi:&#xa0;10.1371/journal.pone.0245424</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245424</ArticleId><ArticleId IdType="pmc">PMC7990309</ArticleId><ArticleId IdType="pubmed">33760825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, et al. . Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. (2013) 210:2223&#x2013;37. doi:&#xa0;10.1084/jem.20131219</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20131219</ArticleId><ArticleId IdType="pmc">PMC3804937</ArticleId><ArticleId IdType="pubmed">24081947</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy WJ. The urgent need for more basic research on SARS-Cov2 infection and vaccines in assessing potential psychoneurological effects using maternal immune activation (MIA) and other preclinical modeling. Brain Behav Immun. (2021) 97:1&#x2013;3. doi:&#xa0;10.1016/j.bbi.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8247198</ArticleId><ArticleId IdType="pubmed">34217811</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. . The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat Neurosci. (2021) 24:368&#x2013;78. doi:&#xa0;10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, Bullock TA, McGary HM, Khan JA, et al. . The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. (2020) 146:105131. doi:&#xa0;10.1016/j.nbd.2020.105131</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105131</ArticleId><ArticleId IdType="pmc">PMC7547916</ArticleId><ArticleId IdType="pubmed">33053430</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. . Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. (2021) 595:565&#x2013;71. doi:&#xa0;10.1038/s41586-021-03710-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Kuang M, Li J, Zhu L, Jia Z, Guo X, et al. . SARS-CoV-2 spike protein interacts with and activates TLR41. Cell Res. (2021) 31:818&#x2013;20. doi:&#xa0;10.1038/s41422-021-00495-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00495-9</ArticleId><ArticleId IdType="pmc">PMC7975240</ArticleId><ArticleId IdType="pubmed">33742149</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Cho W-H, Barcelon E, Kim KH, Hong J, Lee SJ. SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death. Sci Rep. (2022) 12:5496. doi:&#xa0;10.1038/s41598-022-09410-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09410-7</ArticleId><ArticleId IdType="pmc">PMC8970073</ArticleId><ArticleId IdType="pubmed">35361832</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. . Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. (2002) 417:822&#x2013;8. doi:&#xa0;10.1038/nature00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Kaplan N, Wysocki J, Yang W, Lu K, Peng H, et al. . The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation. FASEB J. (2020) 34:10505&#x2013;15. doi:&#xa0;10.1096/fj.202001020R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001020R</ArticleId><ArticleId IdType="pmc">PMC7323146</ArticleId><ArticleId IdType="pubmed">32725927</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. (2008) 82:7264&#x2013;75. doi:&#xa0;10.1128/JVI.00737-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>